iRhythm (IRTC) posts shareholder engagement presentation, Nov 2025

iRhythm Technologies, Inc. (IRTC) furnished an investor presentation as part of its shareholder engagement program.

Rhea-AI Filing Summary

iRhythm Technologies, Inc. (IRTC) furnished an investor presentation as part of its shareholder engagement program. The presentation is included as Exhibit 99.1 to the report.

The materials in this disclosure are provided under Item 7.01 (Regulation FD) and are expressly stated as “furnished,” not “filed,” which means they are not subject to Section 18 liability and are not incorporated into other Securities Act or Exchange Act filings except by specific reference.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did iRhythm Technologies (IRTC) announce in this 8-K?

The company furnished an investor presentation as part of its shareholder engagement program and attached it as Exhibit 99.1.

When was the iRhythm (IRTC) investor presentation issued?

It was issued on November 12, 2025.

Is the iRhythm (IRTC) presentation considered filed with the SEC?

No. It is furnished, not filed, under Item 7.01 and not subject to Section 18 liability.

Where can investors find the presentation from iRhythm (IRTC)?

It is attached to the report as Exhibit 99.1.

Does this 8-K include financial statements?

No. The filing lists exhibits only, including Exhibit 99.1 and the Cover Page Interactive Data File (Exhibit 104).

Who signed the report for iRhythm (IRTC)?

The report was signed by Daniel Wilson, Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 05:17 PM Learn about SEC filing dates

0001388658false00013886582025-11-122025-11-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 12, 2025

iRhythm Technologies, Inc.

(Exact name of Registrant as specified in its charter) 

Delaware			001-37918			20-8149544
(State or other jurisdiction of incorporation or organization)			(Commission File Number)			(I.R.S. Employer Identification Number)

699 8th Street, Suite 600

San Francisco, California 94103

(Address of principal executive office) (Zip Code)

(415) 632-5700

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share			IRTC			The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On November 12, 2025, iRhythm Technologies, Inc. (the “Company”) issued an investor presentation as part of the Company’s shareholder engagement program, a copy of which is attached hereto as Exhibit 99.1.

The information in this Item 7.01 of this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.						Description
99.1						Shareholder Engagement Presentation (November 2025)
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						IRHYTHM TECHNOLOGIES, INC.
Date: November 12, 2025						By:			/s/ Daniel Wilson
									Daniel Wilson
									Chief Financial Officer